ProfileGDS4095 / 202376_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 69% 65% 66% 68% 67% 71% 66% 69% 65% 64% 69% 66% 69% 64% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep16.5670469
GSM709769LY2 SRC1-siRNA tamoxifen treated rep35.6688165
GSM709765LY2 SRC1-siRNA untreated rep35.9651266
GSM709771LY2 SRC1-siRNA untreated rep16.3153768
GSM709772LY2 SRC1-siRNA untreated rep26.1049467
GSM709775LY2 SRC1-siRNA untreated rep47.0138871
GSM709764LY2 control-siRNA tamoxifen treated rep25.9510466
GSM709766LY2 control-siRNA tamoxifen treated rep36.609169
GSM709768LY2 control-siRNA tamoxifen treated rep15.6761465
GSM709777LY2 control-siRNA tamoxifen treated rep45.5919964
GSM709770LY2 control-siRNA untreated rep36.5505769
GSM709773LY2 control-siRNA untreated rep15.9327566
GSM709774LY2 control-siRNA untreated rep26.589569
GSM709776LY2 control-siRNA untreated rep45.454264